AKT1 and colonic neoplasm: These results are consistent with previous studies that demonstrated lunasin interacts with αvβ3 integrin and inhibits Akt activation in human macrophages [15] and that lunasin interacts with α5β1 and inhibits FAK/ERK/NF-κB signaling in colon cancer cells [27].